Penile cancer incidence statistics

Coronavirus (COVID-19)

We have created a central resources hub for Health Professionals which hosts all of our CRUK resources and further materials to help with managing the pandemic. We are updating the information as guidance changes. There is also a page specifically for patients on our about cancer hub.

Health Professional COVID-19 and Cancer Hub

Cases

New cases of penile cancer, 2015-2017, UK

 

Proportion of all cases

Percentage penile cancer is of total cancer cases, 2015-2017, UK

 

Age

Peak rate of penile cancer cases, 2015-2017, UK

 

Trend over time

Change in penile cancer incidence rates since the early 1990s, Males, UK

 

Penile cancer is not among the 20 most common cancers in males in the UK, accounting for less than 1% of all new cancer cases in males (2017).

In females and males combined, penile cancer is not among the 20 most common cancers in the UK, accounting for less than 1% of all new cancer cases (2017).[1-4]

Penile cancer incidence rates (European age-standardised (AS) rates Open a glossary item) are similar to the UK average in all the UK constituent countries.

Penile Cancer (C60), Number of New Cases, Crude and European Age-Standardised (AS) Incidence Rates per 100,000 Population, Males, UK, 2017

  England Scotland Wales Northern Ireland UK
Male Cases 572 83 36 19 710
Crude Rate 2.1 3.1 2.3 2.1 2.2
AS Rate 2.4 3.4 2.5 2.7 2.5
AS Rate - 95% LCL 2.2 2.7 1.7 1.5 2.3
AS Rate - 95% UCL 2.6 4.2 3.3 3.9 2.7
Persons Cases 572 83 36 19 710
Crude Rate 1.0 1.5 1.2 1.0 1.1
AS Rate 1.1 1.6 1.1 1.2 1.1
AS Rate - 95% LCL 1.0 1.2 0.8 0.6 1.1
AS Rate - 95% UCL 1.2 1.9 1.5 1.7 1.2

95% LCL and 95% UCL are the 95% lower and upper confidence limits Open a glossary item  around the AS Rate Open a glossary item

References

  1. Data were provided by the National Cancer Registration and Analysis Service (part of Public Health England), on request through the Office for Data Release, November 2019. Similar data can be found here: https://www.ons.gov.uk/peoplepopulationandcommunity/healthandsocialcare/conditionsanddiseases/bulletins/cancerregistrationstatisticsengland/previousReleases
  2. Data were provided by ISD Scotland on request, April 2019. Similar data can be found here: http://www.isdscotland.org/Health-Topics/Cancer/Publications.
  3. Data were provided by the Welsh Cancer Intelligence and Surveillance Unit, Health Intelligence Division, Public Health Wales on request, December 2019. Similar data can be found here: http://www.wcisu.wales.nhs.uk.
  4. Data were provided by the Northern Ireland Cancer Registry on request, May 2019. Similar data can be found here: http://www.qub.ac.uk/research-centres/nicr/.

About this data

Data is for UK, 2017, ICD-10 C60.

Last reviewed:

Penile cancer incidence is strongly related to age, with the highest incidence rates being in older men. In the UK in 2015-2017, on average each year a third of new cases (33%) were in males aged 75 and over.[1-4]

Age-specific incidence rates rise steadily from around age 35 to 39 and more steeply from age 50 to 54.The highest rates are in in the 90+ age group.

Penile cancer (C60), Average Number of New Cases per Year and Age-Specific Incidence Rates per 100,000 Males, UK, 2015-2017

For penile cancer, like most cancer types, incidence increases with age. This largely reflects cell DNA damage accumulating over time. Damage can result from biological processes or from exposure to risk factors. A drop or plateau in incidence in the oldest age groups often indicates reduced diagnostic activity perhaps due to general ill health.

References

  1. Data were provided by the National Cancer Registration and Analysis Service (part of Public Health England), on request through the Office for Data Release, November 2019. Similar data can be found here: https://www.ons.gov.uk/peoplepopulationandcommunity/healthandsocialcare/conditionsanddiseases/bulletins/cancerregistrationstatisticsengland/previousReleases
  2. Data were provided by ISD Scotland on request, April 2019. Similar data can be found here: http://www.isdscotland.org/Health-Topics/Cancer/Publications.
  3. Data were provided by the Welsh Cancer Intelligence and Surveillance Unit, Health Intelligence Division, Public Health Wales on request, December 2019. Similar data can be found here: http://www.wcisu.wales.nhs.uk.
  4. Data were provided by the Northern Ireland Cancer Registry on request, May 2019. Similar data can be found here: http://www.qub.ac.uk/research-centres/nicr/.

About this data

Data is for UK, 2015-2017, C60.

Last reviewed:

Penile cancer European age-standardised (AS) incidence rates for males increased by 25% in the UK between 1993-1995 and 2015-2017.[1-4].

Over the last decade in the UK (between 2005-2007 and 2015-2017), penile cancer AS incidence rates for males increased by 15%.[1-4]

Penile Cancer (ICD-10 C60), European Age-Standardised Incidence Rates, Males, UK, 1993-2017

Penile cancer incidence rates have varied between age groups in males in the UK since the early 1990s.[1-4] Rates in 0-24s have remained stable, in 25-49s have remained stable, in 50-59s have increased by 38%, in 60-69s have increased by 82%, in 70-79s have increased by 27%, and in 80+s have remained stable.

Penile Cancer (ICD-10 C60), European Age-Standardised Incidence Rates, By Age, Males, UK, 1993-2017

For penile cancer, like most cancer types, incidence trends largely reflect changing prevalence of risk factors and improvements in diagnosis and data recording. Recent incidence trends are influenced by risk factor prevalence in years past, and trends by age group reflect risk factor exposure in birth cohorts.

References

  1. Data were provided by the National Cancer Registration and Analysis Service (part of Public Health England), on request through the Office for Data Release, August 2018. Similar data can be found here: https://www.ons.gov.uk/peoplepopulationandcommunity/healthandsocialcare/conditionsanddiseases/bulletins/cancerregistrationstatisticsengland/previousReleases
  2. Data were provided by ISD Scotland on request, April 2018. Similar data can be found here: http://www.isdscotland.org/Health-Topics/Cancer/Publications.
  3. Data were provided by the Welsh Cancer Intelligence and Surveillance Unit, Health Intelligence Division, Public Health Wales on request, February 2019. Similar data can be found here: http://www.wcisu.wales.nhs.uk.
  4. Data were provided by the Northern Ireland Cancer Registry on request, April 2018. Similar data can be found here: http://www.qub.ac.uk/research-centres/nicr/.

About this data

Data is for UK, 1993-2017, ICD-10 C60.

Last reviewed:

The largest proportion of penile cancer cases occur in the glans penis, with a slightly smaller proportion in the prepuce, and a much smaller proportion in the body of the penis (2010-2012).[1-4]

A large proportion of cases did not have the specific part of the penis recorded in cancer registry data, or overlapped more than one part.[1-4]

Cases and percentages may not sum due to rounding

Reference

  1. Data were provided by the Office for National Statistics on request, July 2014. Similar data can be found here:
    http://www.ons.gov.uk/ons/rel/vsob1/cancer-statistics-registrations--england--series-mb1-/index.html.
  2. Data were provided by ISD Scotland on request, April 2014. Similar data can be found here: http://www.isdscotland.org/Health-Topics/Cancer/Publications/index.asp.
  3. Data were provided by the Welsh Cancer Intelligence and Surveillance Unit on request, April 2014. Similar data can be found here: http://www.wales.nhs.uk/sites3/page.cfm?orgid=242&pid=59080.
  4. Data were provided by the Northern Ireland Cancer Registry on request, June 2014. Similar data can be found here: http://www.qub.ac.uk/research-centres/nicr/CancerInformation/.

About this data

Data is for UK, 2010-2012, ICD-10 C60.

Last reviewed:

Penile cancer incidence rates (European age-standardised (AS) rates Open a glossary item) in England in males are 52% higher in the most deprived quintile compared with the least (2013-2017).[1]

It is estimated that there are around 75 more cases of penile cancer each year in England than there would be if every deprivation quintile had the same age-specific crude incidence rates as the least deprived quintile.

Penile Cancer (C60), Estimated Average Number of Excess Cases per Year and European Age-Standardised Incidence Rates per 100,000 Population, by Deprivation Quintile, England, 2013-2017

References

  1. Calculated by the Cancer Intelligence Team at Cancer Research UK, April 2020. Based on method reported in National Cancer Intelligence Network Cancer by Deprivation in England Incidence, 1996-2010 Mortality, 1997-2011 . Using cancer incidence data 2013-2017 (Public Health England) and population data 2013-2017 (Office for National Statistics) by Indices of Multiple Deprivation 2015 income domain quintile, cancer type, sex, and five-year age band.

About this data

Data is for England, 2013-2017, ICD-10 C60.

Last reviewed:

Cancer stats explained

See information and explanations on terminology used for statistics and reporting of cancer, and the methods used to calculate some of our statistics.

Citation

You are welcome to reuse this Cancer Research UK content for your own work.
Credit us as authors by referencing Cancer Research UK as the primary source. Suggested styles are:

Web content: Cancer Research UK, full URL of the page, Accessed [month] [year].
Publications: Cancer Research UK ([year of publication]), Name of publication, Cancer Research UK.
Graphics (when reused unaltered): Credit: Cancer Research UK.
Graphics (when recreated with differences): Based on a graphic created by Cancer Research UK.

When Cancer Research UK material is used for commercial reasons, we encourage a donation to our life-saving research.
Send a cheque payable to Cancer Research UK to: Cancer Research UK, 2 Redman Place, London, E20 1JQ or

Donate online

We’re now on twitter.
Join the conversation and follow @CRUKHCPs for news, updates and opinion.

@CRUKHCPs

Acknowledgements

We are grateful to the many organisations across the UK which collect, analyse, and share the data which we use, and to the patients and public who consent for their data to be used. Find out more about the sources which are essential for our statistics.